CP-271485

CP-271485 is an experimental small molecule belonging to the benzothiazole class of organic compounds. It acts as a selective inhibitor of macrophage metalloelastase (also known as matrix metalloproteinase 12 or MMP12), an enzyme involved in tissue remodeling and inflammatory processes. The compound has not been approved for clinical use and has not advanced beyond preclinical or early-phase research stages. Its primary mechanism is the inhibition of macrophage metalloelastase activity, which may have implications for diseases involving inflammation or tissue degradation[1].

Other names

(6S)-4-Benzyl-6-(1-methyl-2,2-dioxido-1,3-dihydro-2,1-benzothiazol-5-yl)-3-morpholinone